Chan JA - Search Results

1

Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.

Qian ZR, Ter-Minassian M, Chan JA, Imamura Y, Hooshmand SM, Kuchiba A, Morikawa T, Brais LK, Daskalova A, Heafield R, Lin X, Christiani DC, Fuchs CS, Ogino S, Kulke MH. Qian ZR, et al. Among authors: chan ja. J Clin Oncol. 2013 Sep 20;31(27):3418-25. doi: 10.1200/JCO.2012.46.6946. Epub 2013 Aug 26. J Clin Oncol. 2013. PMID: 23980085 Free PMC article.

2

Physical activity and survival after colorectal cancer diagnosis.

Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Meyerhardt JA, et al. Among authors: chan at, chan ja. J Clin Oncol. 2006 Aug 1;24(22):3527-34. doi: 10.1200/JCO.2006.06.0855. Epub 2006 Jul 5. J Clin Oncol. 2006. PMID: 16822844

3

Hormone replacement therapy and survival after colorectal cancer diagnosis.

Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS. Chan JA, et al. Among authors: chan at. J Clin Oncol. 2006 Dec 20;24(36):5680-6. doi: 10.1200/JCO.2006.08.0580. J Clin Oncol. 2006. PMID: 17179103

4

Emerging therapies for the treatment of patients with advanced neuroendocrine tumors.

Chan JA, Kulke MH. Chan JA, et al. Expert Opin Emerg Drugs. 2007 May;12(2):253-70. doi: 10.1517/14728214.12.2.253. Expert Opin Emerg Drugs. 2007. PMID: 17604500 Review.

5

Family history and survival after colorectal cancer diagnosis.

Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Bass AJ, et al. Among authors: chan ja. Cancer. 2008 Mar 15;112(6):1222-9. doi: 10.1002/cncr.23294. Cancer. 2008. PMID: 18219663 Free article.

6

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, Goldberg RM, Warren RS, Bertagnolli M, Fuchs CS. Chan JA, et al. JAMA. 2008 Jun 4;299(21):2515-23. doi: 10.1001/jama.299.21.2515. JAMA. 2008. PMID: 18523220 Free PMC article.

7

Prediagnostic plasma folate and the risk of death in patients with colorectal cancer.

Wolpin BM, Wei EK, Ng K, Meyerhardt JA, Chan JA, Selhub J, Giovannucci EL, Fuchs CS. Wolpin BM, et al. Among authors: chan ja. J Clin Oncol. 2008 Jul 1;26(19):3222-8. doi: 10.1200/JCO.2008.16.1943. J Clin Oncol. 2008. PMID: 18591557 Free PMC article.

8

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.

Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M, Hahn WC. Firestein R, et al. Among authors: chan ja. Nature. 2008 Sep 25;455(7212):547-51. doi: 10.1038/nature07179. Epub 2008 Sep 14. Nature. 2008. PMID: 18794900 Free PMC article.

9

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.

Wolpin BM, Hezel AF, Abrams T, Blaszkowsky LS, Meyerhardt JA, Chan JA, Enzinger PC, Allen B, Clark JW, Ryan DP, Fuchs CS. Wolpin BM, et al. Among authors: chan ja. J Clin Oncol. 2009 Jan 10;27(2):193-8. doi: 10.1200/JCO.2008.18.9514. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047305 Free PMC article. Clinical Trial.

10

Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.

Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS. Wolpin BM, et al. Among authors: chan at, chan ja. J Clin Oncol. 2009 Jan 10;27(2):176-85. doi: 10.1200/JCO.2008.17.9945. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page